Skip to content
Clinical Trials – home
Queen's University
Sponsor

Queen's University

99 University Avenue, K7L 3N5

About the sponsor

Clinical research in non-small cell lung cancer focuses on patients with completely resected stage IB, stage II, and stage IIIA disease, with attention to PD-L1-expressing and EGFR/ALK-negative tumours.

  • Adjuvant immunotherapy
  • Disease-free survival
  • Resected lung cancer

The oncology portfolio is centred on post-surgical treatment strategies aimed at reducing recurrence risk in resected lung malignancy.

About Specializations

Queen's University runs clinical trials in conditions such as Thermal burn, Non-small cell lung cancer, among others.

All trials

Ongoing trials

Clinical trials registered by this sponsor – none is enrolling right now.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

2 clinical trials

Thermal burn

Not recruiting
Registered drug
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Queen's University
Registered drug
Countries:BulgariaBulgaria
  • Participants:18–64 years · 65+ years
  • Substances:Durvalumab
  • Sponsor:Clinipace Global Limited

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.